Product Pathways - Jak/Stat Pathway
SOCS3 (L210) Antibody #2932
|2932S||100 µl (10 western blots)||---||In Stock||---|
|2932||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|W||1:1000||Human, Mouse, Rat||Endogenous||26||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Species predicted to react based on 100% sequence homology: Monkey, Bovine, Dog.
Specificity / Sensitivity
SOCS3 (L210) Antibody detects endogenous levels of total SOCS3 protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu210 of SOCS3. Antibodies were purified by protein A and peptide affinity chromatography.
The suppressor of cytokine signaling (SOCS) family members are negative regulators of cytokine signal transduction that inhibit the Jak/Stat pathway (1-3). The SOCS family consists of at least 8 members including the originally identified cytokine-inducible SH2-containing protein (CIS1), as well as SOCS1-7. Each SOCS family member contains a central SH2 domain and a conserved carboxy-terminal motif designated as the SOCS box. These proteins are important regulators of cytokine signaling, proliferation, differentiation, and immune responses.
Low levels of SOCS3 are observed in lung, spleen and thymus and, like other SOCS family members, its expression is rapidly induced by a number of factors including interleukins, EPO, IFN-γ, CSF and TNF-α (4). SOCS3 uses its SH2 domain to bind activated Jaks and their cognate receptors to provide negative feedback inhibition. In addition to the initially described inducers of SOCS3 expression, subsequent studies have described SOCS3-mediated negative feedback inhibition for leptin (5), GH (6), chemokine receptors (7), insulin (8), and certain pathogens (9,10). SOCS3 deletion results in embryonic lethality with placental insufficiency (11). SOCS3 signaling has been linked pathologically to allergic responses (12), inflammatory disease (13), endotoxic shock (14), wound repair (15), and obesity (16,17).
- Alexander, W.S. et al. (1999) J Leukoc Biol 66, 588-92.
- Chen, X.P. et al. (2000) Immunity 13, 287-90.
- Hilton, D.J. et al. (1998) Proc Natl Acad Sci USA 95, 114-9.
- Starr, R. et al. (1997) Nature 387, 917-21.
- Bjørbaek, C. et al. (1998) Mol Cell 1, 619-25.
- Adams, T.E. et al. (1998) J Biol Chem 273, 1285-7.
- Soriano, S.F. et al. (2002) J Exp Med 196, 311-21.
- Emanuelli, B. et al. (2000) J Biol Chem 275, 15985-91.
- Stoiber, D. et al. (1999) J Immunol 163, 2640-7.
- Stoiber, D. et al. (2001) J Immunol 166, 466-72.
- Roberts, A.W. et al. (2001) Proc Natl Acad Sci USA 98, 9324-9.
- Seki, Y. et al. (2003) Nat Med 9, 1047-54.
- Shouda, T. et al. (2001) J Clin Invest 108, 1781-8.
- Fang, M. et al. (2005) Cell Mol Immunol 2, 373-7.
- Goren, I. et al. (2006) J Invest Dermatol 126, 477-85.
- Mori, H. et al. (2004) Nat Med 10, 739-43.
- Howard, J.K. et al. (2004) Nat Med 10, 734-8.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 2923 SOCS3 Antibody
- 2779 SOCS2 Antibody
- 9914 Phospho-Stat Antibody Sampler Kit
- 9939 Stat Antibody Sampler Kit
- 9945 Jak Isoform Sampler Kit
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.